UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 122

Sortiert nach

HCV and the kidney

Liver international, 2016-01, Vol.36 (S1), p.28-33

2016

Link zum Volltext

Verfügbarkeit prüfen

Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma

Alimentary pharmacology & therapeutics, 2021-06, Vol.53 (11), p.1166-1182

2021

Link zum Volltext

Verfügbarkeit prüfen

FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

Hepatology (Baltimore, Md.), 2007-07, Vol.46 (1), p.32-36

2007

Link zum Volltext

Verfügbarkeit prüfen

Is elimination of HCV realistic by 2030: France

Liver international, 2021-06, Vol.41 (S1), p.45-49

2021

Link zum Volltext

Verfügbarkeit prüfen

Noninvasive In Vivo Liver Fibrosis Evaluation Using Supersonic Shear Imaging: A Clinical Study on 113 Hepatitis C Virus Patients

Ultrasound in medicine & biology, 2011-09, Vol.37 (9), p.1361-1373

2011

Link zum Volltext

Verfügbarkeit prüfen

Direct‐acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?

Liver international, 2019-03, Vol.39 (3), p.446-447

2019

Link zum Volltext

Verfügbarkeit prüfen

Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C

Annals of internal medicine, 2008-09, Vol.149 (6), p.399

2008

Link zum Volltext

Verfügbarkeit prüfen

Rapid Decline of Liver Stiffness Following Alcohol Withdrawal in Heavy Drinkers

Alcoholism, clinical and experimental research, 2012-08, Vol.36 (8), p.1407-1411

2012

Link zum Volltext

Verfügbarkeit prüfen

Bradyarrhythmias Associated with Sofosbuvir Treatment

The New England journal of medicine, 2015-11, Vol.373 (19), p.1886-1888

2015

Link zum Volltext

Verfügbarkeit prüfen

Grazoprevir/elbasvir combination therapy for HCV infection

Therapeutic Advances in Gastroenterology, 2017-01, Vol.10 (1), p.155-167

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of hepatitis C virus genotype 3-infection

Liver international, 2014-02, Vol.34 (s1), p.18-23

2014

Link zum Volltext

Verfügbarkeit prüfen

Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes

Alimentary Pharmacology & Therapeutics (Suppl), 2021-10, Vol.54 (7), p.952-966

2021

Link zum Volltext

Verfügbarkeit prüfen

The impact of human immunodeficiency virus on viral hepatitis

Liver international, 2011-01, Vol.31 (s1), p.135-139

2011

Link zum Volltext

Verfügbarkeit prüfen

Direct‐acting antivirals and hepatitis B virus (HBV) reactivation in co‐infected HBV/HCV kidney‐transplant recipients

Transplant infectious disease, 2018-06, Vol.20 (3), p.e12864-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

Hepatic medicine: evidence and research, 2016-01, Vol.8 (Issue 1), p.21-26

2016

Link zum Volltext

Verfügbarkeit prüfen

FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients

Hepatology (Baltimore, Md.), 2006-09, Vol.44 (3), p.769-769

2006

Link zum Volltext

Verfügbarkeit prüfen

Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection

Hepatology (Baltimore, Md.), 2012-09, Vol.56 (3), p.861-872

2012

Link zum Volltext

Verfügbarkeit prüfen

Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash

Hepatology (Baltimore, Md.), 2012-06, Vol.55 (6), p.2042-2043

2012

Link zum Volltext

Verfügbarkeit prüfen

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study

Journal of clinical medicine, 2023-05, Vol.12 (11), p.3751

2023

Link zum Volltext

Verfügbarkeit prüfen

HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms

Clinical infectious diseases, 2004-03, Vol.38 (Supplement-2), p.S65-S72

2004

Link zum Volltext

Verfügbarkeit prüfen

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

AIDS (London), 2006-01, Vol.20 (2), p.233-240

2006

Link zum Volltext

Verfügbarkeit prüfen

An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines

Nephrology, dialysis, transplantation, 2017-01, Vol.32 (1), p.32-35

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(106)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

HCV and the kidney

Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma

FIB‐4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest

Is elimination of HCV realistic by 2030: France

Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

Noninvasive In Vivo Liver Fibrosis Evaluation Using Supersonic Shear Imaging: A Clinical Study on 113 Hepatitis C Virus Patients

Direct‐acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic?

Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C

Rapid Decline of Liver Stiffness Following Alcohol Withdrawal in Heavy Drinkers

Bradyarrhythmias Associated with Sofosbuvir Treatment

Grazoprevir/elbasvir combination therapy for HCV infection

Treatment of hepatitis C virus genotype 3-infection

Prospective external validation of a new non‐invasive test for the diagnosis of non‐alcoholic steatohepatitis in patients with type 2 diabetes

The impact of human immunodeficiency virus on viral hepatitis

Direct‐acting antivirals and hepatitis B virus (HBV) reactivation in co‐infected HBV/HCV kidney‐transplant recipients

Daclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real life

FIB-4: A simple, inexpensive and accurate marker of fibrosis in HCV-infected patients

Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash

Histological Characteristics and Management of Hepatitis on Immune Checkpoint Inhibitors: A Retrospective Descriptive Study

HIV Infection and Hepatic Enzyme Abnormalities: Intricacies of the Pathogenic Mechanisms

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

An update on the management of hepatitis C virus-infected patients with stage 4-5 chronic kidney disease while awaiting the revised KDIGO Guidelines

Intravenous ketamine and progressive cholangiopathy in COVID-19 patients

Suchergebnisse filtern